Holen Sie sich die Stockscreener-App
17.97
1.70%
-0.31
Handel nachbörslich:
17.85
-0.12
-0.67%
Schlusskurs vom Vortag:
$18.28
Offen:
$18.28
24-Stunden-Volumen:
1.11M
Relative Volume:
1.30
Marktkapitalisierung:
$1.89B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-150.70M
KGV:
-11.59
EPS:
-1.55
Netto-Cashflow:
$-125.67M
1W Leistung:
+12.10%
1M Leistung:
+14.82%
6M Leistung:
+6.27%
1J Leistung:
-47.15%
1-Tages-Spanne:
$17.64
$18.61
1-Wochen-Bereich:
$15.66
$18.80
52-Wochen-Spanne:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Firmenname
Edgewise Therapeutics Inc
Sektor
Branche
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER
Vergleichen Sie EWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
17.97 | 1.93B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | Goldman | Neutral |
| 2025-07-30 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-30 | Eingeleitet | Guggenheim | Buy |
| 2025-04-02 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-22 | Eingeleitet | Stifel | Hold |
| 2024-11-22 | Eingeleitet | Evercore ISI | Outperform |
| 2024-03-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2022-08-25 | Herabstufung | Goldman | Neutral → Sell |
| 2022-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-28 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Truist Securities reiterates Buy rating on Edgewise Therapeutics stock By Investing.com - Investing.com Canada
Edgewise Therapeutics prepares for pivotal research in cardiovascular medicine - Traders Union
Published on: 2025-11-03 07:00:03 - newser.com
Edgewise Therapeutics (Nasdaq: EWTX) reports 170,750 inducement options to 7 hires - Stock Titan
Real time alert setup for Edgewise Therapeutics Inc. performanceJuly 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
What hedge fund activity signals for Edgewise Therapeutics Inc. stockEntry Point & Scalable Portfolio Growth Ideas - newser.com
Risk vs reward if holding onto Edgewise Therapeutics Inc.July 2025 Market Mood & Safe Entry Trade Reports - newser.com
Strategies to average down on Edgewise Therapeutics Inc.Weekly Stock Report & Daily Profit Maximizing Tips - newser.com
Can Edgewise Therapeutics Inc. stock beat analyst upgradesJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
Detecting price anomalies in Edgewise Therapeutics Inc. with AIWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Real time breakdown of Edgewise Therapeutics Inc. stock performanceWeekly Gains Report & Consistent Profit Alerts - newser.com
What recovery options are there for Edgewise Therapeutics Inc.2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Chart overlay techniques for tracking Edgewise Therapeutics Inc.Take Profit & Safe Capital Growth Trade Ideas - newser.com
What valuation multiples suggest for Edgewise Therapeutics Inc. stockWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Edgewise Therapeutics Inc. stock prediction for this weekJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Edgewise Therapeutics soars 62% after InvestingPro’s April fair value alert By Investing.com - Investing.com Australia
Analyzing Edgewise Therapeutics Inc. with risk reward ratio chartsWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Is Edgewise Therapeutics Inc. stock supported by innovation pipelineGap Down & Expert Approved Trade Ideas - newser.com
Does Edgewise Therapeutics Inc. show high probability of rebound2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.Forecast Cut & AI Based Buy and Sell Signals - newser.com
Moody Aldrich Partners LLC Lowers Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Risk adjusted return profile for Edgewise Therapeutics Inc. analyzedJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
What analysts say about Edgewise Therapeutics Inc stockEconomic Indicators Overview & Superior Wealth Growth - earlytimes.in
Edgewise Therapeutics (NASDAQ:EWTX) Trading Up 9.5%Here's What Happened - MarketBeat
Edgewise Therapeutics (EWTX) Expected to Announce Earnings on Thursday - MarketBeat
Published on: 2025-10-31 05:56:48 - newser.com
Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - ADVFN
How to build a custom watchlist for Edgewise Therapeutics Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Edgewise Therapeutics, Inc. (EWTX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Edgewise Therapeutics set to unveil Q3 2025 results pre-market Nov 6 - Traders Union
Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400 - MSN
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study - MSN
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):